Literature DB >> 29072817

The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data.

Marlon Perera1,2, Nathan Papa1, Daniel Christidis1, Shannon McGrath1, Todd Manning1, Matthew Roberts2, Damien Bolton1, Nathan Lawrentschuk1,3,4, Shomik Sengupta1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29072817     DOI： 10.1111/bju.14065

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  6 in total

Review 1.  Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.

Authors:  Adithya Balasubramanian; Ashray Gunjur; Andrew Weickhardt; Nathan Papa; Damien Bolton; Nathan Lawrentschuk; Marlon Perera
Journal:  World J Urol       Date:  2022-01-27       Impact factor: 4.226

2.  Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label study.

Authors:  Rodolfo Hurle; Paolo Casale; Emanuela Morenghi; Alberto Saita; Nicolòmaria Buffi; Giovanni Lughezzani; Piergiuseppe Colombo; Roberto Contieri; Nicola Frego; Giorgio Guazzoni; Massimo Lazzeri
Journal:  BJUI Compass       Date:  2020-07-01

Review 3.  Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update.

Authors:  Sandra Guallar-Garrido; Esther Julián
Journal:  Immunotargets Ther       Date:  2020-02-13

4.  Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.

Authors:  Makito Miyake; Kota Iida; Nobutaka Nishimura; Tatsuki Miyamoto; Kiyohide Fujimoto; Ryotaro Tomida; Kazumasa Matsumoto; Kazuyuki Numakura; Junichi Inokuchi; Shuichi Morizane; Takahiro Yoneyama; Yoshiaki Matsumura; Takashige Abe; Masaharu Inoue; Takeshi Yamada; Naoki Terada; Shuya Hirao; Motohide Uemura; Yuto Matsushita; Rikiya Taoka; Takashi Kobayashi; Takahiro Kojima; Yoshiyuki Matsui; Hiroshi Kitamura; Hiroyuki Nishiyama
Journal:  BMC Cancer       Date:  2021-03-11       Impact factor: 4.430

5.  Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients.

Authors:  Roberto Carando; Emiliano Soldini; Simone Cotrufo; Michele Zazzara; Giuseppe M Ludovico
Journal:  Arab J Urol       Date:  2020-08-31

6.  A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation.

Authors:  Andrew Morton; Michael Williams; Marlon Perera; Sachinka Ranasinghe; Patrick E Teloken; Marissa Williams; Eric Chung; Matthew J Roberts
Journal:  World J Mens Health       Date:  2020-07-30       Impact factor: 5.400
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.